Maverick Capital’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5M | Buy |
8,363,813
+3,164,595
| +61% | +$7.75M | 0.31% | 48 |
|
|
2025
Q1 | $34.7M | Buy |
5,199,218
+318
| +0% | +$2.12K | 0.61% | 44 |
|
|
2024
Q4 | $65.4M | Buy |
5,198,900
+1,080,228
| +26% | +$13.6M | 1.18% | 30 |
|
|
2024
Q3 | $76.1M | Buy |
4,118,672
+190,360
| +5% | +$3.52M | 1.48% | 23 |
|
|
2024
Q2 | $84.6M | Buy |
3,928,312
+40,000
| +1% | +$861K | 1.6% | 21 |
|
|
2024
Q1 | $105M | Sell |
3,888,312
-145,756
| -4% | -$3.93M | 1.97% | 12 |
|
|
2023
Q4 | $121M | Sell |
4,034,068
-1,595,902
| -28% | -$47.8M | 2.43% | 6 |
|
|
2023
Q3 | $115M | Buy |
5,629,970
+1,250,000
| +29% | +$25.6M | 2.61% | 7 |
|
|
2023
Q2 | $87M | Sell |
4,379,970
-27,653
| -0.6% | -$549K | 1.86% | 15 |
|
|
2023
Q1 | $75.5M | Buy |
4,407,623
+1,011,805
| +30% | +$17.3M | 1.91% | 11 |
|
|
2022
Q4 | $66.5M | Buy |
3,395,818
+863,452
| +34% | +$16.9M | 1.57% | 15 |
|
|
2022
Q3 | $40.4M | Hold |
2,532,366
| – | – | 0.91% | 23 |
|
|
2022
Q2 | $34.8M | Buy |
2,532,366
+399,200
| +19% | +$5.49M | 0.86% | 23 |
|
|
2022
Q1 | $33.8M | Buy |
2,133,166
+238,200
| +13% | +$3.78M | 0.59% | 36 |
|
|
2021
Q4 | $41.4M | Buy |
1,894,966
+234,850
| +14% | +$5.13M | 0.47% | 43 |
|
|
2021
Q3 | $49.6M | Buy |
1,660,116
+1,486,229
| +855% | +$44.4M | 0.5% | 40 |
|
|
2021
Q2 | $7.7M | Buy |
+173,887
| New | +$7.7M | 0.07% | 84 |
|